| Literature DB >> 26718251 |
Christine Leong1, Jitender Sareen2, Murray W Enns3, James Bolton4, Silvia Alessi-Severini5.
Abstract
Community pharmacists frequently encounter patients suspected to be at risk of medication misuse, divergence and overdose; yet, little research exists in describing how pharmacists effectively identify and intervene during these encounters. This study aimed to understand the barriers and facilitators in community pharmacy practice using a focus group design to help inform policymakers in the development of effective and feasible strategies for limiting the means of medication misuse. Findings revealed three themes: (1) patient-level barriers (deciphering signs of misuse); (2) pharmacist-level barriers (type of practice experience); and (3) system-level barriers (prescriber, third-party payer). Insight into pharmacy practice provided a foundation for future study to explore strategies for improving care for at-risk patients.Entities:
Mesh:
Year: 2015 PMID: 26718251 DOI: 10.12927/hcq.2015.24434
Source DB: PubMed Journal: Healthc Q ISSN: 1710-2774